Home/Filings/4/0001992352-26-000003
4//SEC Filing

Guarini Kathryn 4

Accession 0001992352-26-000003

CIK 0000872589other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:16 PM ET

Size

7.1 KB

Accession

0001992352-26-000003

Insider Transaction Report

Form 4
Period: 2026-01-02
Transactions
  • Award

    Common Stock

    2026-01-02+155603 total
  • Award

    Non-Qualified Stock Option (right to buy)

    2026-01-02+1,9621,962 total
    Exercise: $772.76Exp: 2036-01-02Common Stock (1,962 underlying)
Footnotes (2)
  • [F1]Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.
  • [F2]On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Issuer

REGENERON PHARMACEUTICALS, INC.

CIK 0000872589

Entity typeother

Related Parties

1
  • filerCIK 0001992352

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:16 PM ET
Size
7.1 KB